We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$188B
AUM Growth
+$6.54B
(+3.6%)
Cap. Flow
-$6.74B
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
16.94%
Holding
4,804
New
439
Increased
1,801
Reduced
1,889
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$387M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$183M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$144M |
| 4 |
Zai Lab
ZLAB
|
+$123M |
| 5 |
Halliburton
HAL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$832M |
| 2 |
Alibaba
BABA
|
+$374M |
| 3 |
Microsoft
MSFT
|
+$321M |
| 4 |
Apple
AAPL
|
+$273M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Healthcare | 10.34% |
| 3 | Financials | 8.3% |
| 4 | Consumer Discretionary | 7.2% |
| 5 | Communication Services | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
MiMedx Group
MDXG
$622M
| $301K | ﹤0.01% |
49,703
+5,611
| +13% | +$39K |
|
3977
Arcos Dorados Holdings
ARCO
$1.75B
| $300K | ﹤0.01% |
51,389
-375,100
| -88% | -$1.9M |
|
3978
C4 Therapeutics
CCCC
$387M
| $298K | ﹤0.01% |
9,288
+758
| +9% | +$30K |
|
3979
ALX Oncology
ALXO
$260M
| $297K | ﹤0.01% |
13,834
+9,456
| +216% | +$408K |
|
|
DFTX
3980
Definium Therapeutics
DFTX
$5.55B
| $297K | ﹤0.01% |
14,339
-1,483
| -9% | -$47.3K |
|
3981
Compugen
CGEN
$225M
| $295K | ﹤0.01% |
68,465
+3,637
| +6% | +$19.7K |
|
|
CTLP
3982
DELISTED
Cantaloupe
CTLP
| $295K | ﹤0.01% |
33,081
-206
| -0.6% | -$2.05K |
|
|
YMAB
3983
DELISTED
Y-mAbs Therapeutics
YMAB
| $294K | ﹤0.01% |
18,066
+1,124
| +7% | +$24K |
|
|
OGI
3984
Organigram Holdings
OGI
$136M
| $293K | ﹤0.01% |
41,908
-3,050
| -7% | -$25.9K |
|
|
KLRS
3985
Kalaris Therapeutics
KLRS
$96.4M
| $293K | ﹤0.01% |
988
-168
| -15% | -$77.9K |
|
|
MMAT
3986
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $292K | ﹤0.01% |
+1,185
| New | +$489K |
|
|
OCFT
3987
DELISTED
OneConnect Financial Technology
OCFT
| $290K | ﹤0.01% |
11,737
-12,945
| -52% | -$384K |
|
3988
Sunoco
SUN
$14.6B
| $290K | ﹤0.01% |
7,118
-5,678
| -44% | -$225K |
|
|
KBAL
3989
DELISTED
Kimball International
KBAL
| $290K | ﹤0.01% |
28,466
+707
| +3% | +$7.65K |
|
3990
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $289K | ﹤0.01% |
10,074
-805
| -7% | -$23.3K |
|
3991
Lands' End
LE
$382M
| $289K | ﹤0.01% |
14,715
+843
| +6% | +$19.6K |
|
|
REVG
3992
DELISTED
REV Group
REVG
| $289K | ﹤0.01% |
20,493
+594
| +3% | +$9.39K |
|
|
SHCO
3993
DELISTED
Soho House & Co
SHCO
| $289K | ﹤0.01% |
+22,616
| New | +$271K |
|
3994
Traeger
COOK
$186M
| $287K | ﹤0.01% |
+472
| New | +$395K |
|
3995
AEye
LIDR
$58.4M
| $287K | ﹤0.01% |
+1,983
| New | +$306K |
|
3996
GeneDx Holdings
WGS
$2.01B
| $287K | ﹤0.01% |
+1,950
| New | +$436K |
|
3997
CALL
Axalta
AXTA
$7.76B
| $285K | ﹤0.01% |
+8,600
| New | +$273K |
|
3998
CALL
Deutsche Bank
DB
$69.8B
| $285K | ﹤0.01% |
22,800
-1,715,001
| -99% | -$21.9M |
|
3999
Duluth Holdings
DLTH
$158M
| $285K | ﹤0.01% |
18,844
+5,555
| +42% | +$83.9K |
|
|
HYZN
4000
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $285K | ﹤0.01% |
+881
| New | +$287K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2021 Portfolio in Review
As of Q4 2021, Credit Suisse held 4,804 positions worth $188B, up 3.6% from $182B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $6.74B in Q4 2021, closing 333 positions and reducing 1,889 holdings. Its most notable exit was Kansas City Southern, an estimated $126M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Bank of America Series L worth $48.1M.
- Credit Suisse's largest Q4 2021 buy was Bank of America Series L: 33,252 shares worth $48.1M.
- Credit Suisse added most to Linde in Q4 2021, an estimated $387M increase.
- Credit Suisse's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $832M.
- Credit Suisse fully exited Kansas City Southern in Q4 2021, selling an estimated $126M.
- Credit Suisse's ten largest holdings make up 17% of its $188B portfolio in Q4 2021.
- Credit Suisse opened 439 new positions and closed 333 in Q4 2021.
- Credit Suisse's portfolio value rose 3.6% quarter-over-quarter to $188B.
Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.